T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer
- PMID: 22777621
- DOI: 10.1007/s00330-012-2578-z
T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer
Abstract
Objectives: To determine the diagnostic value of T2-weighted signal intensity evolution in the tumour for detection of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer.
Methods: Thirty-nine patients diagnosed with locally advanced adenocarcinoma and treated with chemoradiotherapy (CRT), followed by surgery, underwent magnetic resonance imaging (MRI) before and after CRT on 1.5-T MRI using T2-weighted fast spin-echo (FSE) imaging. The relative T2-weighted signal intensity (rT2wSI) distribution in the tumour and post-CRT residual tissue was characterised by means of the descriptive statistical parameters, such as the mean, 95th percentile and standard deviation (SD). Receiver operating characteristic curves were used to determine the diagnostic potential of the CRT-induced alterations (Δ) in rT2wSI descriptives. The tumour regression grade (TRG) served as a histopathological reference standard.
Results: CRT induced a significant decrease of approximately 50% in all rT2wSI descriptives in complete responders (TRG1). This drop was significantly larger than for incomplete response groups (TRG2-TRG4). The ΔrT2wSI descriptives produced a high diagnostic performance for identification of complete responders, e.g. Δ95th percentile, ΔSD and Δmean resulted in accuracy of 92%, 90% and 82%, respectively.
Conclusions: Quantitative assessment of the CRT-induced changes in the tumour T2-weighted signal intensity provides high diagnostic performance for selection of complete responders.
Similar articles
-
T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.Eur Radiol. 2018 Dec;28(12):5231-5240. doi: 10.1007/s00330-018-5520-1. Epub 2018 Jun 1. Eur Radiol. 2018. PMID: 29858637
-
MRI prediction of pathological response in locally advanced rectal cancer: when apparent diffusion coefficient radiomics meets conventional volumetry.Clin Radiol. 2020 Oct;75(10):798.e1-798.e11. doi: 10.1016/j.crad.2020.06.023. Epub 2020 Jul 22. Clin Radiol. 2020. PMID: 32712007
-
Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.Curr Med Imaging. 2022;18(10):1061-1069. doi: 10.2174/1573405618666220303111026. Curr Med Imaging. 2022. PMID: 35240976 Free PMC article.
-
Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.J Magn Reson Imaging. 2019 Mar;49(3):885-893. doi: 10.1002/jmri.26254. Epub 2018 Aug 5. J Magn Reson Imaging. 2019. PMID: 30079601
-
Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.Abdom Radiol (NY). 2018 Sep;43(9):2221-2230. doi: 10.1007/s00261-018-1457-8. Abdom Radiol (NY). 2018. PMID: 29332248
Cited by
-
Predicting complete response: is there a role for non-operative management of rectal cancer?J Gastrointest Oncol. 2015 Apr;6(2):241-6. doi: 10.3978/j.issn.2078-6891.2014.110. J Gastrointest Oncol. 2015. PMID: 25830042 Free PMC article. Review.
-
T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.Eur Radiol. 2018 Dec;28(12):5231-5240. doi: 10.1007/s00330-018-5520-1. Epub 2018 Jun 1. Eur Radiol. 2018. PMID: 29858637
-
CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA.J Cancer. 2020 Sep 23;11(22):6565-6570. doi: 10.7150/jca.49252. eCollection 2020. J Cancer. 2020. PMID: 33046977 Free PMC article.
-
Magnetic Resonance of Rectal Cancer Response to Therapy: An Image Quality Comparison between 3.0 and 1.5 Tesla.Biomed Res Int. 2020 Oct 10;2020:9842732. doi: 10.1155/2020/9842732. eCollection 2020. Biomed Res Int. 2020. PMID: 33102603 Free PMC article. Clinical Trial.
-
Imaging in rectal cancer with emphasis on local staging with MRI.Indian J Radiol Imaging. 2015 Apr-Jun;25(2):148-61. doi: 10.4103/0971-3026.155865. Indian J Radiol Imaging. 2015. PMID: 25969638 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials